Our active surveillance process uses sophisticated prostate MRI imaging to analyze the makeup of your tumor and provide a personalized risk assessment. This process is used for small, nonaggressive tumors that have a low probability of impacting your health and are not likely to grow or spread.
Your doctor may recommend active surveillance and periodic imaging tests to monitor your prostate cancer and determine whether treatment is needed. Active surveillance includes a prostate-specific antigen test every six-to-12 months and a prostate MRI every one or two years. A biopsy may be taken at the time of your prostate MRI as well.